PT3277690T - Compostos espirocíclicos - Google Patents
Compostos espirocíclicosInfo
- Publication number
- PT3277690T PT3277690T PT167742329T PT16774232T PT3277690T PT 3277690 T PT3277690 T PT 3277690T PT 167742329 T PT167742329 T PT 167742329T PT 16774232 T PT16774232 T PT 16774232T PT 3277690 T PT3277690 T PT 3277690T
- Authority
- PT
- Portugal
- Prior art keywords
- spirocyclic compounds
- spirocyclic
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562142946P | 2015-04-03 | 2015-04-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3277690T true PT3277690T (pt) | 2020-03-24 |
Family
ID=57007413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT167742329T PT3277690T (pt) | 2015-04-03 | 2016-03-31 | Compostos espirocíclicos |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US10525036B2 (OSRAM) |
| EP (1) | EP3277690B1 (OSRAM) |
| JP (1) | JP6737533B2 (OSRAM) |
| KR (1) | KR20170132307A (OSRAM) |
| CN (1) | CN107849053B (OSRAM) |
| AU (1) | AU2016242940B2 (OSRAM) |
| BR (1) | BR112017021194A2 (OSRAM) |
| CA (1) | CA2981055A1 (OSRAM) |
| CY (1) | CY1123019T1 (OSRAM) |
| DK (1) | DK3277690T3 (OSRAM) |
| ES (1) | ES2788160T3 (OSRAM) |
| HR (1) | HRP20200805T1 (OSRAM) |
| HU (1) | HUE049481T2 (OSRAM) |
| IL (1) | IL254662B (OSRAM) |
| LT (1) | LT3277690T (OSRAM) |
| MX (1) | MX379622B (OSRAM) |
| PL (1) | PL3277690T3 (OSRAM) |
| PT (1) | PT3277690T (OSRAM) |
| RS (1) | RS60340B1 (OSRAM) |
| RU (1) | RU2745069C2 (OSRAM) |
| SG (1) | SG11201707911VA (OSRAM) |
| SI (1) | SI3277690T1 (OSRAM) |
| SM (1) | SMT202000279T1 (OSRAM) |
| TW (1) | TWI705067B (OSRAM) |
| WO (1) | WO2016161160A1 (OSRAM) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10308609B2 (en) * | 2014-09-17 | 2019-06-04 | Zeno Royalties & Milestones, LLC | Bicyclic compounds |
| CN107849053B (zh) | 2015-04-03 | 2020-10-30 | 里科瑞尔姆Ip控股有限责任公司 | 螺环化合物 |
| BR112019005305A2 (pt) * | 2016-10-05 | 2019-07-02 | Zeno Royalties & Milestones Llc | compostos espirocíclicos |
| JP7128816B2 (ja) | 2016-12-08 | 2022-08-31 | ボード オブ レジェンツ，ザ ユニバーシティ オブ テキサス システム | 疾患の治療のための二重ロイシンジッパー（ｄｌｋ）キナーゼのビシクロ［１．１．１］ペンタン阻害剤 |
| SG11202007251XA (en) * | 2018-01-31 | 2020-08-28 | Aptinyx Inc | Spiro-lactam nmda receptor modulators and uses thereof |
| EP3956330A4 (en) | 2019-04-18 | 2023-01-18 | The Johns Hopkins University | SUBSTITUTED 2-AMINO-PYRAZOLYL-[1,2,4]TRIAZOLO[1,5A]PYRIDINE DERIVATIVES AND THEIR USE |
| US11560366B2 (en) | 2019-10-21 | 2023-01-24 | Board Of Regents, The University Of Texas System | Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease |
| CN115124542A (zh) * | 2022-07-08 | 2022-09-30 | 河南师范大学 | 羟基苯取代吡唑酮并吲唑[螺]吡唑酮类化合物的合成方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR057579A1 (es) * | 2005-11-23 | 2007-12-05 | Merck & Co Inc | Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac) |
| US8546404B2 (en) | 2005-12-13 | 2013-10-01 | Merck Sharp & Dohme | Compounds that are ERK inhibitors |
| WO2008063609A2 (en) | 2006-11-17 | 2008-05-29 | Polyera Corporation | Diimide-based semiconductor materials and methods of preparing and using the same |
| WO2009105500A1 (en) | 2008-02-21 | 2009-08-27 | Schering Corporation | Compounds that are erk inhibitors |
| WO2010027567A2 (en) | 2008-07-23 | 2010-03-11 | Schering Corporation | Tricyclic spirocycle derivatives and methods of use thereof |
| WO2011041152A1 (en) * | 2009-09-30 | 2011-04-07 | Schering Corporation | Novel compounds that are erk inhibitors |
| WO2011071860A2 (en) | 2009-12-07 | 2011-06-16 | Alnylam Pharmaceuticals, Inc. | Compositions for nucleic acid delivery |
| ES2609579T3 (es) | 2011-08-29 | 2017-04-21 | VIIV Healthcare UK (No.5) Limited | Derivados espiro de diamina bicíclica como inhibidores de la unión del VIH |
| CN103130775B (zh) * | 2011-11-22 | 2015-09-30 | 山东亨利医药科技有限责任公司 | 作为酪氨酸激酶抑制剂的吲哚满酮衍生物 |
| US8987264B2 (en) * | 2012-11-09 | 2015-03-24 | Bristol-Myers Squibb Company | 1,3,5-triazine derivatives of spiro bicyclic oxalamide-compounds for treatment of hepatitis C |
| US9447025B2 (en) | 2013-03-14 | 2016-09-20 | Kalyra Pharmaceuticals, Inc. | Bicyclic analgesic compounds |
| CN105732636B (zh) | 2014-12-30 | 2020-04-21 | 广东东阳光药业有限公司 | 杂芳化合物及其在药物中的应用 |
| CN107849053B (zh) | 2015-04-03 | 2020-10-30 | 里科瑞尔姆Ip控股有限责任公司 | 螺环化合物 |
| BR112019005305A2 (pt) | 2016-10-05 | 2019-07-02 | Zeno Royalties & Milestones Llc | compostos espirocíclicos |
-
2016
- 2016-03-31 CN CN201680028591.0A patent/CN107849053B/zh not_active Expired - Fee Related
- 2016-03-31 RU RU2017133973A patent/RU2745069C2/ru active
- 2016-03-31 BR BR112017021194A patent/BR112017021194A2/pt not_active IP Right Cessation
- 2016-03-31 HR HRP20200805TT patent/HRP20200805T1/hr unknown
- 2016-03-31 EP EP16774232.9A patent/EP3277690B1/en active Active
- 2016-03-31 JP JP2017552060A patent/JP6737533B2/ja not_active Expired - Fee Related
- 2016-03-31 PT PT167742329T patent/PT3277690T/pt unknown
- 2016-03-31 SG SG11201707911VA patent/SG11201707911VA/en unknown
- 2016-03-31 RS RS20200577A patent/RS60340B1/sr unknown
- 2016-03-31 SI SI201630764T patent/SI3277690T1/sl unknown
- 2016-03-31 PL PL16774232T patent/PL3277690T3/pl unknown
- 2016-03-31 SM SM20200279T patent/SMT202000279T1/it unknown
- 2016-03-31 MX MX2017012553A patent/MX379622B/es unknown
- 2016-03-31 HU HUE16774232A patent/HUE049481T2/hu unknown
- 2016-03-31 CA CA2981055A patent/CA2981055A1/en not_active Abandoned
- 2016-03-31 WO PCT/US2016/025345 patent/WO2016161160A1/en not_active Ceased
- 2016-03-31 AU AU2016242940A patent/AU2016242940B2/en not_active Ceased
- 2016-03-31 DK DK16774232.9T patent/DK3277690T3/da active
- 2016-03-31 LT LTEP16774232.9T patent/LT3277690T/lt unknown
- 2016-03-31 KR KR1020177031578A patent/KR20170132307A/ko not_active Ceased
- 2016-03-31 US US15/563,926 patent/US10525036B2/en not_active Expired - Fee Related
- 2016-03-31 ES ES16774232T patent/ES2788160T3/es active Active
- 2016-04-01 TW TW105110691A patent/TWI705067B/zh not_active IP Right Cessation
-
2017
- 2017-09-25 IL IL254662A patent/IL254662B/en active IP Right Grant
-
2019
- 2019-03-15 US US16/354,949 patent/US10493060B2/en not_active Expired - Fee Related
-
2020
- 2020-01-06 US US16/734,857 patent/US20200268714A1/en not_active Abandoned
- 2020-04-10 CY CY20201100356T patent/CY1123019T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL265752A (en) | Spirocyclic compounds | |
| TWI561516B (en) | Substituted dihydroisoquinolinone compounds | |
| GB201510019D0 (en) | Compounds | |
| GB201508747D0 (en) | Compounds | |
| GB201514754D0 (en) | Compounds | |
| IL254662A0 (en) | Spirocyclic compounds | |
| GB201514751D0 (en) | Compounds | |
| SMT202100338T1 (it) | Composti | |
| GB201508864D0 (en) | Compounds | |
| IL253813A0 (en) | Compounds of the diaza-benzofluoroanthrene type and preparations containing these compounds | |
| SI3331885T1 (sl) | Spojine | |
| GB201510493D0 (en) | Compounds | |
| GB201521682D0 (en) | Compounds | |
| GB201503926D0 (en) | Compounds | |
| GB201501115D0 (en) | Compounds | |
| GB201508857D0 (en) | Compounds | |
| GB201521440D0 (en) | Compounds | |
| GB201516059D0 (en) | Compounds | |
| GB201512279D0 (en) | Compounds | |
| GB201511387D0 (en) | Compounds | |
| GB201511064D0 (en) | Compounds | |
| GB201510910D0 (en) | Compounds | |
| GB201510760D0 (en) | Compounds | |
| GB201508866D0 (en) | Compounds | |
| GB201508453D0 (en) | Compounds |